Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IDegLira vs Basal-Bolus in Hospital-to-Home Transition
NCT05767255Phase 3Unknown
- Sponsor
- Hospital Universitario San Ignacio
- Start
- Dec 2022
- Primary completion
- Aug 2023
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of insulin degludec + liraglutide in type 2 diabetes mellitus (T2DM), sponsored by Hospital Universitario San Ignacio. Status: unknown.
02
Drugs
insulin degludec + liraglutide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT05767255.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05767255.